DrugPatentWatch Database Preview
Endothelin Receptor Antagonist Drug Class List
» See Plans and Pricing
Drugs in Drug Class: Endothelin Receptor Antagonist
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sigmapharm Labs Llc | AMBRISENTAN | ambrisentan | TABLET;ORAL | 208354-001 | Apr 10, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Sigmapharm Labs Llc | AMBRISENTAN | ambrisentan | TABLET;ORAL | 208354-002 | Apr 10, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan | AMBRISENTAN | ambrisentan | TABLET;ORAL | 208441-001 | Mar 28, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan | AMBRISENTAN | ambrisentan | TABLET;ORAL | 208441-002 | Mar 28, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Cipla | AMBRISENTAN | ambrisentan | TABLET;ORAL | 210715-001 | Apr 26, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
